Porszász, RóbertMatsumoto, Mirei2025-05-222025-05-222024-05-03https://hdl.handle.net/2437/390264The use of oral contraceptives has long been epidemiologically known to reduce the incidence of ovarian cancer. Recently new data suggested that epigenetic changes play a vital role in the carcinogenesis of ovarian cancer. It proposes not only potential therapeutic targets and biomarkers but also a realistic opportunity for chemo prevention of ovarian cancer by combined oral contraceptives.34enOral contraceptivesOvarian cancerMedicineHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.